Weifeng Shang

892 total citations
22 papers, 598 citations indexed

About

Weifeng Shang is a scholar working on Pulmonary and Respiratory Medicine, Nephrology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Weifeng Shang has authored 22 papers receiving a total of 598 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 7 papers in Nephrology and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Weifeng Shang's work include Dialysis and Renal Disease Management (4 papers), COVID-19 Clinical Research Studies (3 papers) and Heart Failure Treatment and Management (3 papers). Weifeng Shang is often cited by papers focused on Dialysis and Renal Disease Management (4 papers), COVID-19 Clinical Research Studies (3 papers) and Heart Failure Treatment and Management (3 papers). Weifeng Shang collaborates with scholars based in China and Germany. Weifeng Shang's co-authors include Yali Ren, Yuanyuan Li, Gang Xu, Shuwang Ge, Junwu Dong, Wěi Li, Rui Zeng, Ming Tian, Yi Yang and Min Han and has published in prestigious journals such as PLoS ONE, Journal of Medical Virology and International Immunopharmacology.

In The Last Decade

Weifeng Shang

22 papers receiving 585 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weifeng Shang China 12 181 165 133 96 86 22 598
Fernando Caravaca‐Fontán Spain 16 163 0.9× 109 0.7× 390 2.9× 51 0.5× 54 0.6× 92 779
Matthieu Jamme France 15 142 0.8× 89 0.5× 120 0.9× 49 0.5× 44 0.5× 54 617
Boonphiphop Boonpheng United States 17 104 0.6× 99 0.6× 140 1.1× 87 0.9× 27 0.3× 59 714
Steven Grangé France 13 350 1.9× 77 0.5× 162 1.2× 39 0.4× 38 0.4× 45 847
Takeshi Nishida Japan 16 113 0.6× 70 0.4× 50 0.4× 226 2.4× 54 0.6× 31 713
Trevor L. Nydam United States 17 140 0.8× 259 1.6× 34 0.3× 104 1.1× 144 1.7× 81 1.0k
Steven Menez United States 13 40 0.2× 82 0.5× 245 1.8× 30 0.3× 31 0.4× 47 459
Nicholas Carlson Denmark 17 139 0.8× 52 0.3× 141 1.1× 32 0.3× 30 0.3× 65 876
Sagar Ranka United States 17 133 0.7× 120 0.7× 20 0.2× 112 1.2× 72 0.8× 72 824
Patricio Rojas Chile 10 87 0.5× 27 0.2× 320 2.4× 111 1.2× 90 1.0× 29 1.0k

Countries citing papers authored by Weifeng Shang

Since Specialization
Citations

This map shows the geographic impact of Weifeng Shang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weifeng Shang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weifeng Shang more than expected).

Fields of papers citing papers by Weifeng Shang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weifeng Shang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weifeng Shang. The network helps show where Weifeng Shang may publish in the future.

Co-authorship network of co-authors of Weifeng Shang

This figure shows the co-authorship network connecting the top 25 collaborators of Weifeng Shang. A scholar is included among the top collaborators of Weifeng Shang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weifeng Shang. Weifeng Shang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shang, Weifeng, et al.. (2023). Human blood metabolites and risk of severe COVID‐19: A Mendelian randomization study. European Journal of Clinical Investigation. 53(11). e14079–e14079. 3 indexed citations
2.
Wen, Zhenliang, Limin Chen, Lidi Zhang, et al.. (2023). Thymopentin plays a key role in restoring the function of macrophages to alleviate the sepsis process. International Immunopharmacology. 126. 111295–111295. 1 indexed citations
3.
Wei, Honglan, et al.. (2023). The number of valvular insufficiency is a strong predictor of cardiovascular and all-cause mortality in hemodialysis patients. International Urology and Nephrology. 55(11). 2915–2924. 1 indexed citations
4.
Shang, Weifeng, et al.. (2022). Thymosin alpha1 use in adult COVID-19 patients: A systematic review and meta-analysis on clinical outcomes. International Immunopharmacology. 114. 109584–109584. 7 indexed citations
5.
Li, Hua, Liping Dong, Xiaohong Song, et al.. (2021). Correlation between home systolic blood pressure variability and cognitive impairment in maintenance hemodialysis patients. Seminars in Dialysis. 35(2). 129–137. 7 indexed citations
6.
Shang, Weifeng, Yuanyuan Li, Hua Li, et al.. (2020). Correlation between laboratory parameters on admission and outcome of COVID-19 in maintenance hemodialysis patients. International Urology and Nephrology. 53(1). 165–169. 14 indexed citations
7.
Li, Qing, Yimin Huang, Weifeng Shang, et al.. (2020). The Predictive Value of Urinary Kidney Injury Molecular 1 for the Diagnosis of Contrast-Induced Acute Kidney Injury after Cardiac Catheterization: A Meta-Analysis. Journal of Interventional Cardiology. 2020. 1–9. 10 indexed citations
8.
Ren, Yali, Dan Hu, Weifeng Shang, et al.. (2019). Determinants for low bone mineral density in pre-school children: a matched case-control study in Wuhan, China. Journal of Pediatric Endocrinology and Metabolism. 32(7). 739–748. 3 indexed citations
9.
Li, Yuanyuan, Weifeng Shang, Qiaofa Lu, et al.. (2018). Prevalence of pulmonary hypertension in peritoneal dialysis patients: a meta-analysis. International Urology and Nephrology. 51(1). 175–180. 2 indexed citations
10.
Shang, Weifeng, Yuanyuan Li, Yali Ren, et al.. (2018). Prevalence of pulmonary hypertension in patients with chronic kidney disease without dialysis: a meta-analysis. International Urology and Nephrology. 50(8). 1497–1504. 9 indexed citations
11.
12.
Shang, Weifeng, et al.. (2017). Nephrolithiasis and risk of hypertension: a meta-analysis of observational studies. BMC Nephrology. 18(1). 344–344. 37 indexed citations
13.
Yang, Yi, et al.. (2017). Proton-pump inhibitors use, and risk of acute kidney injury: a meta-analysis of observational studies. Drug Design Development and Therapy. Volume 11. 1291–1299. 64 indexed citations
14.
Shang, Weifeng, et al.. (2017). History of kidney stones and risk of chronic kidney disease: a meta-analysis. PeerJ. 5. e2907–e2907. 29 indexed citations
15.
Ning, Yong, Weifeng Shang, Menglan Li, et al.. (2016). Analysis of 4931 renal biopsy data in central China from 1994 to 2014. Renal Failure. 38(7). 1021–1030. 35 indexed citations
16.
Guo, Shuiming, Weifeng Shang, Qing Li, et al.. (2016). Pregnancy Outcomes in Chinese Patients with Systemic Lupus Erythematosus (SLE): A Retrospective Study of 109 Pregnancies. PLoS ONE. 11(7). e0159364–e0159364. 31 indexed citations
17.
Shang, Weifeng, Lixi Li, Shuai Huang, et al.. (2016). Chronic Kidney Disease and the Risk of New-Onset Atrial Fibrillation: A Meta-Analysis of Prospective Cohort Studies. PLoS ONE. 11(5). e0155581–e0155581. 26 indexed citations
18.
Shang, Weifeng, Liu Huang, Li Li, et al.. (2016). Cancer risk in patients receiving renal replacement therapy: A meta-analysis of cohort studies. Molecular and Clinical Oncology. 5(3). 315–325. 36 indexed citations
19.
Yang, Yi, Yong Ning, Weifeng Shang, et al.. (2016). Association of peripheral arterial disease with all-cause and cardiovascular mortality in hemodialysis patients: a meta-analysis. BMC Nephrology. 17(1). 17 indexed citations
20.
Shang, Weifeng, Yong Ning, Menglan Li, et al.. (2015). Incidence of Cancer in ANCA-Associated Vasculitis: A Meta-Analysis of Observational Studies. PLoS ONE. 10(5). e0126016–e0126016. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fernando Caravaca‐Fontán Breakdown of academic impact, for papers by Matthieu Jamme Breakdown of academic impact, for papers by Boonphiphop Boonpheng Breakdown of academic impact, for papers by Steven Grangé Breakdown of academic impact, for papers by Takeshi Nishida Breakdown of academic impact, for papers by Trevor L. Nydam Breakdown of academic impact, for papers by Steven Menez Breakdown of academic impact, for papers by Nicholas Carlson Breakdown of academic impact, for papers by Sagar Ranka Breakdown of academic impact, for papers by Patricio Rojas
Rankless by CCL
2026